Estrogen receptor alpha is essential for the proliferation of prostatic smooth muscle cells stimulated by 17β-estradiol and insulin-like growth factor 1

Cell Biochemistry and Function

Volumn 29, Issue 2, 2011, Pages 120-125

  Zhou, Dawei ^a   Li, Shiwen ^a   Wang, Xinghuan ^a   Cheng, Bei ^b   Ding, Xiegang ^a  

^a WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Cyclin D1; Estradiol; Estrogen receptor alpha; Insulin like growth factor 1; Prostatic smooth muscle cell; Small interfering RNA

Indexed keywords

CYCLIN D1; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; SHORT HAIRPIN RNA; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DNA BINDING; DRUG INHIBITION; ENZYME REGULATION; FLOW CYTOMETRY; MALE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATIC SMOOTH MUSCLE CELLS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; WESTERN BLOTTING;

ANIMALS; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MICE, INBRED BALB C; MYOCYTES, SMOOTH MUSCLE; PROSTATE; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION;

EID: 79952211992     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1731     Document Type: Article

References (24)

1. Roehrborn CG. Pathology of benign prostatic hyperplasia. Int J Impot Res 2008; 20(Suppl. 3): S11-S18.
2. Untergasser G, Madersbacher S, Berger P. Benign prostatic hyperplasia: age-related tissue-remodeling. Exp Gerontol 2005; 40: 121-128.
3. Deering RE, Bigler SA, King J, et al. Morphometric quantitation of stroma inhuman benign prostatic hyperplasia. Urology 1994; 44: 64-70.
4. Shapiro E, Hartanto V, Lepor H. Quantifying the smooth muscle content of the prostate using double-immunoenzymatic staining and color assisted image analysis. J Urol 1992; 147: 1167-1170.
5. Thomas JA, Keenan EJ. Effects of estrogens on the prostate. J Androl 1994; 15: 97-99.
6. Tsurusaki T, Aoki D, Kanetake H, et al. Zone-dependent expression of estrogen receptors alpha and beta in human benign prostatic hyperplasia. J Clin Endocrinol Metab 2003; 88: 1333-1340.
7. Makela S, Strauss L, Kuiper G, et al. Differential expression of estrogen receptors alpha and beta in adult rat accessory sex glands and lower urinary tract. Mol Cell Endocrinol 2000; 164: 109-116.
8. Prins GS, Birch L, Couse JF, et al. Estrogen imprinting of the developing prostate gland is mediated through stromal estrogen receptor alpha: studies with alphaERKO and betaERKO mice. Cancer Res 2001; 61: 6089-6097.
9. Pollak M. Insulin-like growth factors and prostate cancer. Epidemiol Rev 2001; 23: 59-66.
10. Pollak MN, Schernhammer ES, Hankinson SE. Insulin-like growth factors and neoplasia. Nat Rev Cancer 2004; 4: 505-518.
11. Steiner MS. Review of peptide growth factors in benign prostatic hyperplasia and urological malignancy. J Urol 1995; 153: 1085-1096.
12. Wang YZ, Wong YC. Sex hormone-induced prostatic carcinogenesis in the noble rat: the role of insulin-like growth factor-I (IGF-I) and vascular endothelial growth factor (VEGF) in the development of prostate cancer. Prostate 1998; 35: 165-177.
13. Klotz DM, Hewitt SC, Ciana P, et al. Requirement of estrogen receptor-alpha in insulin-like growth factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor cross-talk. J Biol Chem 2002; 277: 8531-8537.
14. Kashima H, Shiozawa T, Miyamoto T, et al. Autocrine stimulation of IGF1 in estrogen-induced growth of endometrial carcinoma cells: involvement of the mitogen-activated protein kinase pathway followed by up-regulation of cyclin D1 and cyclin E. Endocr Relat Cancer 2009; 16: 113-122.
15. Ricciardelli C, Horsfall DJ, Skinner JM, et al. Development and characterization of primary cultures of smooth muscle cells from the fibromuscular stroma of the guinea pig prostate in vitro. Cell Dev Biol 1989; 25: 1016-1024.
16. Musatov S, Chen W, Pfaff DW, et al. RNAi-mediated silencing of estrogen receptor {alpha} in the ventromedial nucleus of hypothalamus abolishes female sexual behaviors. Proc Natl Acad Sci USA 2006; 103: 10456-10460.
17. Jarred RA, Cancilla B, Prins GS, et al. Evidence that estrogens directly alter androgen-regulated prostate development. Endocrinology 2000; 141: 3471-3477.
18. Kozak I, Bartsch W, Krieg M, et al. Nuclei of stroma: site of highest estrogen concentration in human benign prostatic hyperplasia. Prostate 1982; 3: 433-438.
19. Luo Y, Waladali W, Li S, et al. 17beta-estradiol affects proliferation and apoptosis of rat prostatic smooth muscle cells by modulating cell cycle transition and related proteins. Cell Biol Int 2008; 32: 899-905.
20. Soulitzis N, Karyotis I, Delakas D, et al. Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia. Int J Oncol 2006; 29: 305-314.
21. Hewitt SC, Li Y, Li L, et al. Estrogen-mediated regulation of Igf1 transcription and uterine growth involves direct binding of estrogen receptor alpha to estrogen-responsive elements. J Biol Chem 2009; 285: 2676-2685.
22. Donnellan R, Chetty R. Cyclin D1 and human neoplasia. Mol Pathol 1998; 51: 1-7.
23. Barbacid M. Mammalian cyclin-dependent kinases. Trends Biochem Sci 2005; 30: 630-641.
24. Liu MM, Albanese C, Anderson CM, et al. Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression. J Biol Chem 2002; 277: 24353-24360.